The Enterprise Value as of September 2024 (TTM) for Cellectar Biosciences, Inc. (CLRB) is 35.08M

According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.08M. This represents a change of -4.49% compared to the average of 36.73M of the last 4 quarters.

Cellectar Biosciences, Inc. (CLRB) Historical Enterprise Value (quarterly & annually)

How has CLRB Enterprise Value performed in the past?

The mean historical Enterprise Value of Cellectar Biosciences, Inc. over the last ten years is 1.26M. The current 35.08M Enterprise Value has changed 279.08% with respect to the historical average. Over the past ten years (40 quarters), CLRB's Enterprise Value was at its highest in in the March 2024 quarter at 75.56M. The Enterprise Value was at its lowest in in the December 2020 quarter at -28053149.00.

Cellectar Biosciences, Inc. (CLRB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cellectar Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cellectar Biosciences, Inc. (CLRB) Average Enterprise Value

How has CLRB Enterprise Value performed in the past?

The current Enterprise Value of Cellectar Biosciences, Inc. (CLRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cellectar Biosciences, Inc. (CLRB) Enterprise Value vs. Peers

How is CLRB’s Enterprise Value compared to its peers?

Cellectar Biosciences, Inc.’s Enterprise Value is less than Diffusion Pharmaceuticals Inc. (0), greater than Monopar Therapeutics Inc. (-1447403.00), greater than Pulmatrix, Inc. (9.05M), greater than Tenax Therapeutics, Inc. (-6324963.00), greater than Bio-Path Holdings, Inc. (3.75M), greater than Catalyst Biosciences, Inc. (-1337813.00), greater than Capricor Therapeutics, Inc. (19.42M), less than NextCure, Inc. (137.70M), greater than Longboard Pharmaceuticals, Inc. (21.40M), less than Lumos Pharma, Inc. (1.20B), greater than ImmunoCellular Therapeutics, Ltd. (22.23M), greater than Bolt Biotherapeutics, Inc. (15.63M), less than Applied Molecular Transport Inc. (37.21M), greater than Aileron Therapeutics, Inc. (-5743713.00), less than Benitec Biopharma Inc. (39.80M), less than null (70.22M),

Build a custom stock screener for Cellectar Biosciences, Inc. (CLRB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectar Biosciences, Inc. (CLRB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.